Breast cancer Follow-Up overhaul: fewer hospital visits may be just as safe

NCT ID NCT07616258

Recruiting now Knowledge-focused Sponsor: Royal College of Surgeons, Ireland Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether women who finished treatment for early-stage breast cancer can safely reduce their hospital follow-up visits from five years to just two years, while still getting yearly mammograms. About 560 women will take part, with half following the usual schedule and half stopping clinic visits after two years. The goal is to see if fewer appointments can reduce stress and improve quality of life without missing any cancer recurrences.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a simpler, less stressful follow-up schedule for breast cancer survivors, with fewer hospital visits and more care from their family doctor.
What could go wrong: This is an early-stage study with 560 participants, so results may not apply to everyone. There is a small risk that reducing visits could delay detection of a recurrence, though annual mammograms continue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Beaumont RCSI Cancer Centre
RECRUITING

Beaumont, Dublin, D09V2N0, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.